A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15–070) in combination with docetaxel in patients with relapsed non-small cell lung cancer (NSCLC)

Eric B. Haura, C. A. Williams, Alberto Chiappori, Joëlla W. Adams, Donald W. Northfelt

DOI: 10.1200/jco.2008.26.15_suppl.19035

Journal of Clinical Oncology

Data up to Jan 2025

Published2008

Citations3

References0

Fields

Medicine Internal medicine Gastroenterology Pharmacology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15–070) in… (2008) – Journal of Clinical Oncology | Metascience Observatory Explorer